Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1983-9-20
|
pubmed:abstractText |
The characteristic behavioral effect of methamphetamine (MA) at 2.5 mg/kg was enhanced locomotor activity which lasted over 2.5 hr. At 10.0 mg/kg MA, stereotyped behavior was predominant and lasted over 3 hr. The behavioral effect of 5.0 mg/kg MA was of the mixed type. MA at 5.0 and 10.0 mg/kg lowered the brain NE level from 2 hr after drug treatment, while the accumulation of MHPG-SO4 was increased over 2 hr at 2.5 and 5.0 mg/kg MA. The accumulation of HVA was significantly increased at 10.0 mg/kg MA over 3 hr. Accordingly, the behavioral effects of MA at the earlier period were compatible with the biochemical effects of MA. The behavioral effects during the 2- to 4-hr period, however, seem to be unrelated to the actions on brain catecholamines. Measurement of brain MA concentrations revealed that approx. 2 micrograms/g in the brain may be necessary to produce enhanced locomotor activity and the increased accumulation of brain MHPG-SO4. It appeared that approx. 8 to 9 micrograms/g MA in the brain was required to produce characteristic stereotyped behavior and the increased accumulation of HVA. Therefore, the behavioral and biochemical effects of MA were correlated with the brain MA concentrations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Homovanillic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Methamphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Methoxyhydroxyphenylglycol,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-5198
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-40
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6683768-Amphetamine,
pubmed-meshheading:6683768-Animals,
pubmed-meshheading:6683768-Behavior, Animal,
pubmed-meshheading:6683768-Brain,
pubmed-meshheading:6683768-Brain Chemistry,
pubmed-meshheading:6683768-Catecholamines,
pubmed-meshheading:6683768-Dopamine,
pubmed-meshheading:6683768-Homovanillic Acid,
pubmed-meshheading:6683768-Humans,
pubmed-meshheading:6683768-Male,
pubmed-meshheading:6683768-Methamphetamine,
pubmed-meshheading:6683768-Methoxyhydroxyphenylglycol,
pubmed-meshheading:6683768-Mice,
pubmed-meshheading:6683768-Norepinephrine,
pubmed-meshheading:6683768-Stereotyped Behavior,
pubmed-meshheading:6683768-Time Factors
|
pubmed:year |
1983
|
pubmed:articleTitle |
Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
|
pubmed:publicationType |
Journal Article
|